Skip to main content

GOLDMAN SACHS GROUP INC

Position in IMNM — Immunome Inc.

CIK 886982 NEW YORK, NY

Position in IMNM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$32,049,641
+$7,960,362 QoQ
Shares Held
1,512,489
+37.3% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 200 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in IMNM Over Time

Shares Held

Position Value (USD)

Derivatives in IMNM

reported options exposure · as of Dec 31, 2025
CallValue
$1,153,476
CallShares
53,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. IMNM ranks #89 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMNM

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,049,641 1,512,489
2026-03-31 $24,089,279 1,101,476
2025-12-31 $16,168,532 752,725
2025-12-31 $1,153,476 53,700
2025-09-30 $2,446,757 208,946
2025-06-30 $4,451,146 478,618
2025-03-31 $1,300,921 193,302
2024-12-31 $2,907,341 273,761
2024-09-30 $8,311,586 568,508
2024-06-30 $2,229,400 184,248
2024-03-31 $8,187,935 331,764